A detailed history of Orion Portfolio Solutions, LLC transactions in Novartis Ag stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 32,423 shares of NVS stock, worth $3.34 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
32,423
Previous 31,344 3.44%
Holding current value
$3.34 Million
Previous $3.34 Million 11.78%
% of portfolio
0.04%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$106.13 - $120.89 $114,514 - $130,440
1,079 Added 3.44%
32,423 $3.73 Million
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $182,918 - $212,163
1,976 Added 6.73%
31,344 $3.34 Million
Q1 2024

May 09, 2024

SELL
$95.27 - $108.47 $55,923 - $63,671
-587 Reduced 1.96%
29,368 $2.84 Million
Q4 2023

Feb 09, 2024

SELL
$92.27 - $101.54 $176,604 - $194,347
-1,914 Reduced 6.01%
29,955 $3.02 Million
Q3 2023

Nov 01, 2023

SELL
$94.73 - $105.13 $5,589 - $6,202
-59 Reduced 0.18%
31,869 $3.25 Million
Q2 2023

Aug 17, 2023

BUY
$92.52 - $104.91 $332,609 - $377,151
3,595 Added 12.69%
31,928 $3.22 Million
Q2 2023

Aug 14, 2023

SELL
$92.52 - $104.91 $46,907 - $53,189
-507 Reduced 1.76%
28,333 $2.86 Million
Q1 2023

Aug 30, 2023

SELL
$80.03 - $92.81 $247,132 - $286,597
-3,088 Reduced 9.67%
28,840 $2.65 Million
Q1 2023

May 15, 2023

BUY
$80.03 - $92.81 $2.31 Million - $2.68 Million
28,840 New
28,840 $2.65 Million
Q3 2020

Nov 13, 2020

SELL
$82.14 - $91.0 $33,513 - $37,128
-408 Closed
0 $0
Q2 2020

Aug 19, 2020

SELL
$80.93 - $91.1 $18,937 - $21,317
-234 Reduced 36.45%
408 $36,000
Q1 2020

May 15, 2020

BUY
$70.67 - $99.01 $20,706 - $29,009
293 Added 83.95%
642 $53,000
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $29,438 - $33,284
349 New
349 $33,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Orion Portfolio Solutions, LLC Portfolio

Follow Orion Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.